PMEF
BNGO icon

Point72 Middle East FZE’s Bionano Genomics BNGO Stock Holding History

Point72 Middle East FZE’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-539
Closed -$197K – 1479
2023
Q2 		$197K Buy
+539
New +$243K 0.01% 1066

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Point72 Middle East FZE's BNGO Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 539 shares — an estimated $197K sold.

Point72 Middle East FZE first reported a position in BNGO in Q2 2023 and held it in 1 quarter. The position peaked at $197K in Q2 2023. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 539 Bionano Genomics shares in Q3 2023, an estimated $197K.
  • Point72 Middle East FZE first reported a position in Bionano Genomics in Q2 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Bionano Genomics position peaked at $197K in Q2 2023.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.